Entegris, Inc. (ENTG) To Go Ex-Dividend on April 30th

Entegris, Inc. (NASDAQ:ENTG) declared a quarterly dividend on Wednesday, April 16th, Wall Street Journal reports. Stockholders of record on Wednesday, April 30th will be given a dividend of 0.10 per share by the semiconductor company on Wednesday, May 21st. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.50%. The ex-dividend date of this dividend is Wednesday, April 30th.

Entegris has raised its dividend payment by an average of 18.6% per year over the last three years. Entegris has a dividend payout ratio of 9.6% meaning its dividend is sufficiently covered by earnings. Analysts expect Entegris to earn $4.38 per share next year, which means the company should continue to be able to cover its $0.40 annual dividend with an expected future payout ratio of 9.1%.

Entegris Trading Up 1.3 %

Shares of NASDAQ ENTG opened at $80.73 on Monday. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.86 and a current ratio of 3.08. The business’s 50 day moving average price is $87.46 and its 200-day moving average price is $98.28. Entegris has a fifty-two week low of $60.75 and a fifty-two week high of $147.57. The company has a market cap of $12.22 billion, a price-to-earnings ratio of 41.83, a PEG ratio of 1.50 and a beta of 1.36.

Entegris (NASDAQ:ENTG) last announced its quarterly earnings data on Thursday, February 6th. The semiconductor company reported $0.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.77 by $0.07. Entegris had a return on equity of 12.83% and a net margin of 9.03%. On average, sell-side analysts expect that Entegris will post 3.51 earnings per share for the current year.

Insider Buying and Selling

In other Entegris news, SVP Olivier Blachier sold 984 shares of the stock in a transaction on Friday, February 21st. The stock was sold at an average price of $108.00, for a total transaction of $106,272.00. Following the sale, the senior vice president now owns 10,903 shares in the company, valued at approximately $1,177,524. This represents a 8.28 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Clinton M. Haris sold 12,652 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $106.92, for a total value of $1,352,751.84. Following the sale, the senior vice president now owns 34,820 shares in the company, valued at $3,722,954.40. This trade represents a 26.65 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.67% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on ENTG shares. StockNews.com cut shares of Entegris from a “hold” rating to a “sell” rating in a research note on Saturday, April 19th. KeyCorp decreased their price objective on Entegris from $141.00 to $130.00 and set an “overweight” rating on the stock in a report on Monday, April 14th. Mizuho decreased their price objective on Entegris from $125.00 to $120.00 and set an “outperform” rating on the stock in a report on Tuesday, January 7th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $120.00 price target on shares of Entegris in a report on Friday, February 7th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, Entegris currently has a consensus rating of “Moderate Buy” and a consensus price target of $123.50.

Entegris Company Profile

Entegris, Inc develops, manufactures, and supplies microcontamination control products, specialty chemicals, and advanced materials handling solutions in North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia. It operates in three segments: Materials Solutions (MS); Microcontamination Control (MC); and Advanced Materials Handling (AMH).